NIPH Clinical Trials Search

Basic Information

Recruitment status	recruiting
Health condition(s) or Problem(s) studied
Date of first enrollment	31/01/2020
Target sample size	2350
Countries of recruitment	Japan,Asia except Japan,North America,South America,Europe,Oceania
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 339 Other agents relating to blood and body fluides Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 339 Other agents relating to blood and body fluides Dosage and Administration for Investigational material : Generic name etc : INN of investigational material : - Therapeutic category code : 339 Other agents relating to blood and body fluides Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	efficacy other
Secondary Outcome	safety efficacy exploratory pharmacokinetics pharmacodynamics pharmacogenomics

Key inclusion & exclusion criteria

Age minimum	>= 40age old
Age maximum	Not applicable
Gender	Both
Include criteria
Exclude criteria